p. 1−15
2383-2746
Vol.31/No.1
p. 16−26
2383-2746
Vol.31/No.1
p. 27−35
2383-2746
Vol.31/No.1
p. 36−45
2383-2746
Vol.31/No.1
p. 46−57
2383-2746
Vol.31/No.1
p. 58−66
2383-2746
Vol.31/No.1
p. 67−75
2383-2746
Vol.31/No.1
0.05).Therefore, this SNPs could not be used as a useful molecular biomarker to predict genetic susceptibility for autism spectrum disorder in Iranian-Azeri patients.]]>
p. 76−81
2383-2746
Vol.31/No.1
p. 82−93
2383-2746
Vol.31/No.1
p. 94−105
2383-2746
Vol.31/No.1
p. 106−113
2383-2746
Vol.31/No.1
p. 114−120
2383-2746
Vol.31/No.1